ETF Managers Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $1.35M | Sell |
2,818
-822
| -23% | -$394K | 0.04% | 169 |
|
|
2022
Q4 | $1.53M | Buy |
3,640
+390
| +12% | +$164K | 0.07% | 122 |
|
|
2022
Q3 | $1.36M | Sell |
3,250
-671
| -17% | -$280K | 0.04% | 179 |
|
|
2022
Q2 | $1.95M | Buy |
3,921
+673
| +21% | +$334K | 0.06% | 165 |
|
|
2022
Q1 | $1.89M | Sell |
3,248
-1,022
| -24% | -$593K | 0.04% | 210 |
|
|
2021
Q4 | $3.24M | Buy |
4,270
+861
| +25% | +$653K | 0.06% | 187 |
|
|
2021
Q3 | $2.55M | Sell |
3,409
-2,167
| -39% | -$1.62M | 0.05% | 181 |
|
|
2021
Q2 | $3.6M | Sell |
5,576
-224
| -4% | -$145K | 0.06% | 167 |
|
|
2021
Q1 | $3.27M | Sell |
5,800
-300
| -5% | -$169K | 0.06% | 157 |
|
|
2020
Q4 | $3.51M | Buy |
6,100
+304
| +5% | +$175K | 0.08% | 141 |
|
|
2020
Q3 | $2.99M | Buy |
5,796
+3,471
| +149% | +$1.79M | 0.09% | 135 |
|
|
2020
Q2 | $1.01M | Buy |
+2,325
| New | +$1.01M | 0.04% | 177 |
|